Furthermore, it disrupts adipose tissue homeostasis by increasing pro-inflammatory adipokines (resistin, leptin) while reducing adiponectin, thereby exacerbating metabolic disturbances in PCOS [72,73,74]. Here, RETN is linked to polycystic ovary syndrome.